Ministry of Chemicals and Fertilizers : press release · 13 March 2026 · pibtracker filter

Affordable Price of Injections for Serious Injuries

PRID2239572 MinistryMinistry of Chemicals and Fertilizers : Released13 March 2026 Reading6 min

Posted On: 13 MAR 2026 3:42PM by PIB Delhi As informed by Ministry of Health & Family Welfare, many of the drugs required for the treatment of rare diseases are expensive as they are imported from outside the country. National Policy for Rare Diseases 2021 (NPRD, 2021) facilitates financial and medical support of up to Rs. 50 Lakh per patient for treatment of any of the 63 identified rare diseases through 15 designated Centres of Excellence. Further, the Union Cabinet on 24.02.2021 has approved Production Linked Incentive (PLI) Scheme for Pharmaceuticals with the objective to enhance India’s manufacturing capabilities by increasing investment and production in the pharmaceuticals sector and contributing to product diversification to high-value goods in the pharmaceutical sector. Risdiplam, which is the API used in formulations to treat Spinal Muscular Atrophy, is being manufactured by Biophore India Pharmaceuticals Private Limited under PLI Scheme for Pharmaceuticals. Further, Natco Pharma Limited has launched the generic version of the drug in Indian market and is manufacturing the product domestically. This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today. ***** PC/PM (Release ID: 2239572) Visitor Counter : 329 Read this release in: Urdu , हिन्दी Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals Affordable Price of Injections for Serious Injuries Posted On: 13 MAR 2026 3:42PM by PIB Delhi As informed by Ministry of Health & Family Welfare, many of the drugs required for the treatment of rare diseases are expensive as they are imported from outside the country. National Policy for Rare Diseases 2021 (NPRD, 2021) facilitates financial and medical support of up to Rs. 50 Lakh per patient for treatment of any of the 63 identified rare diseases through 15 designated Centres of Excellence. Further, the Union Cabinet on 24.02.2021 has approved Production Linked Incentive (PLI) Scheme for Pharmaceuticals with the objective to enhance India’s manufacturing capabilities by increasing investment and production in the pharmaceuticals sector and contributing to product diversification to high-value goods in the pharmaceutical sector. Risdiplam, which is the API used in formulations to treat Spinal Muscular Atrophy, is being manufactured by Biophore India Pharmaceuticals Private Limited under PLI Scheme for Pharmaceuticals. Further, Natco Pharma Limited has launched the generic version of the drug in Indian market and is manufacturing the product domestically. This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today. ***** PC/PM (Release ID: 2239572) As informed by Ministry of Health & Family Welfare, many of the drugs required for the treatment of rare diseases are expensive as they are imported from outside the country. National Policy for Rare Diseases 2021 (NPRD, 2021) facilitates financial and medical support of up to Rs. 50 Lakh per patient for treatment of any of the 63 identified rare diseases through 15 designated Centres of Excellence. Further, the Union Cabinet on 24.02.2021 has approved Production Linked Incentive (PLI) Scheme for Pharmaceuticals with the objective to enhance India’s manufacturing capabilities by increasing investment and production in the pharmaceuticals sector and contributing to product diversification to high-value goods in the pharmaceutical sector. Risdiplam, which is the API used in formulations to treat Spinal Muscular Atrophy, is being manufactured by Biophore India Pharmaceuticals Private Limited under PLI Scheme for Pharmaceuticals. Further, Natco Pharma Limited has launched the generic version of the drug in Indian market and is manufacturing the product domestically. This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today.   ***** PC/PM " /> var mPlayer = document.getElementById("background_music"); var mPlayAction = document.getElementById("playbutton"); var isPlaying = false; function playAudio() { mPlayer.play(); isPlaying = true; document.getElementById('stopA').style.display = "block"; document.getElementById('playA').style.display = "none"; } function pauseAudio() { mPlayer.pause(); isPlaying = false; document.getElementById('playA').style.display = "block"; document.getElementById('stopA').style.display = "none"; } //function HandleAudio() { // if (isPlaying == true) { // //Playing already Pause it // pauseAudio(); // } else { // //Play the music // playAudio(); // } //} var synth = window.speechSynthesis; function CleanHtml(html) { html = html.replace(/ /gi, ''); return html; } function stripHtml(html) { let tmp = document.createElement("DIV"); tmp.innerHTML = CleanHtml(html); return tmp.textContent || tmp.innerText || ""; } $(document).ready(function () { //for responsive tables $("table").each(function () { if (!$(this).closest(".table-responsive").length) { $(this).wrap(" "); } }); var width = $(window).width(); if (width $(document).ready(function () { var width = $(window).width(); if (width @media print { .sticky-social, .sticky-social_mb, .pull-right, #printPDF { display: none !important; } } .f_vl { padding-right: 30px; font-size: 17px; cursor: pointer; } .log_oo { // width: 20%; display: flex; justify-content: space-between; } .log_oo img { width: 150px; /*width: 100%; height: auto;*/ } .sticky-social_mb { position: fixed; bottom: 0px; padding: 0px; margin: 0px; width: 100%; } .social_mb { list-style: none; display: flex; width: 100%; margin-bottom: -8px; } .social_mb a { padding: 8px 0px; font-size: 30px; transition: all 0.8s ease-in-out; width: 20% !important; text-align: center; } .section1 { position: relative; padding: 10px 0px; width: 100%; } .sticky-social { position: fixed; top: 20px; left: 0px; padding: 0px; margin: 0px; } .social { list-style: none; } .social a li { padding: 8px 12px; font-size: 25px; transition: all 0.8s ease-in-out; } .social a li:hover { margin-right: -30px; box-shadow: 2px 5px 10px grey; } .social a li:hover .fa { margin-left: 20px; } .fb_b { /* background-color: rgb(59, 89, 152);*/ background-color: rgba(65,103,178,255); } .twitter_r { /* background-color: rgb(29, 161, 242);*/ background-color: #000000; } .whatsapp_r { /* background-color: rgb(77, 194, 71);*/ background-color: rgba(13,191,67,255); } .fa-envelope_r { /* background-color: rgb(219, 68, 55);*/ background-color: #e2123d; } .fa-linkedin_r { background-color: rgb(0, 119, 181); } @media only screen and (max-device-width: 767px) { p span img { max-width: 90% !important; height: auto !important; } p img { max-width: 90% !important; height: auto !important; } h2 { font-size: 20px !important; font-weight: 600 !important; } h3 { font-size: 18px !important; font-weight: 600 !important; } } /* === Film Roll Badge Styling(IFFI2025 countdown) === */ .film-roll-badge { position: absolute; top:82%; right: 20px; width: 230px; height: 70px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 18px, #6e2b8b 18px, #6e2b8b 36px ); border-top: 8px solid #9a2375; border-bottom: 8px solid #9a2375; border-radius: 8px; overflow: hidden; box-shadow: 0 4px 12px rgba(0, 0, 0, 0.4); animation: moveFilm 8s linear infinite; z-index: 10; } /* film sprocket holes */ .film-roll-badge::before, .film-roll-badge::after { content: ""; position: absolute; width: 100%; height: 10px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 10px, #fff 10px, #fff 20px ); left: 0; z-index: 2; } .film-roll-badge::before { top: -4px; } .film-roll-badge::after { bottom: -4px; } .film-roll-inner { position: relative; height: 100%; display: flex; align-items: center; justify-content: center; animation: flicker 2s infinite ease-in-out; } .countdown-text { font-size: 1.3rem; font-weight: 700; color: #fff; text-shadow: 0 0 6px rgba(255, 255, 255, 0.4), 0 0 10px #000; white-space: nowrap; } /* === Animations === */ @keyframes moveFilm { 0% { background-position: 0 0; } 100% { background-position: 120px 0; } } @keyframes flicker { 0%, 100% { opacity: 1; } 50% { opacity: 0.9; } 25% { opacity: 0.95; } 75% { opacity: 0.85; } } /* === Responsive Adjustments === */ @media (max-width: 1500px) { .film-roll-badge { top: 68%; right: 18px; /* width: 220px; */ height: 65px; font-size: 0.85rem; } .press-section { margin-top: 35px; } } @media (max-width: 992px) { .film-roll-badge { top: 52%; right: 10px; width: 200px; height: 60px; } } @media (max-width: 768px) { .film-roll-badge { top: 56%; right: 10px; width: 124px; height: 55px; } .countdown-text { font-size: 0.9rem; } } @media (max-width: 576px) { .film-roll-badge { top: 59%; right: 5px; /* width: 160px; */ height: 50px; } .countdown-text { font-size: 0.85rem; } } const festivalStart = new Date("2025-11-20T00:00:00").getTime(); const festivalEnd = new Date("2025-11-28T23:59:59").getTime(); const countdownElement = document.getElementById("countdown"); const interval = setInterval(() => { const now = new Date().getTime(); // BEFORE FESTIVAL — show days + hours left if (now = festivalStart && now el.style.width = "350px"); clearInterval(interval); } }, 1000); //

Original PIB release
pib.gov.in · PRID 2239572

Open on PIB ↗

Affordable Price of Injections for Serious Injuries

More from this day